California, U.K. firms in stem cell licensing deal

07/7/2005 | Yahoo!

Palo Alto, Calif.-based StemCells announced a licensing deal giving the U.K.'s ReNeuron rights to its technology for using human neural stem cells. The U.K. firm is testing a stem cell therapy for stroke and working to develop stem cell treatments for diabetes, Parkinson's disease, Huntington's disease and certain eye disorders.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Food & Drug Associate
Confidential
Washington, D.C., DC